Meet the Bioconjugation Insights Editorial Board

Bioconjugation Insights 2025; 1(2), 69

DOI: 10.18609/bci2025.013

Published: 8 July
Infographic
Zhaohui Sunny Zhou , Nimish Gupta, Kalli Catcott, Esohe Idusogie, Elizabeth Love, Roy Baynes, Vince Rotello, Rakesh Dixit, David Simpson , Ning Wang, Sung-Ju Moon

An integral part of the team that brings you Bioconjugation Insights is our fantastic Editorial Advisory Board (EAB). The members of our EAB are critical to our success, providing their time and expertise to steer our content and make sure we’re featuring the topics and authors that matter to our audience.

We surveyed a selection of our EAB members to provide insights on their careers, interests, and their visions for the future of both the journal and the exciting fields it serves.



You can also download and print the infographic (please note, the PDF is not interactive).


Have a look at articles written by our Editorial Board members below:

Advancing ADC innovation through multidisciplinary integration

Nimish Gupta

Lauren Coyle, Launch Commissioning Editor, Bioconjugation Insights, speaks with Nimish Gupta, Bioconjugation Process Development Lead, Regeneron, about the integration of his multidisciplinary expertise to advance ADC development. He discusses innovations in process design, analytical strategies, and technology transfer to accelerate clinical readiness and expand ADC applications beyond oncology.

Industry insights, June 2025

Esohe Idusogie

Bioconjugation Insights is delighted to bring you all the latest news in the bioconjugation space in this new Industry Insights article. Brought to you by one of our esteemed Editorial Advisory Board members, this article highlights the latest developments in collaborations, regulatory changes, marketing trends, and R&D in the field. Additionally, it provides insights into key clinical trials, innovations in tools and technology, and notable conferences and publications.

Striking a balance between ADC safety and efficacy

Rakesh Dixit

On October 9, 2024, Lauren Coyle, Launch Commissioning Editor, Bioconjugation Insights, spoke to Rakesh Dixit, Cofounder, President and CSO of Regio Biosciences, CEO of Bionavigen, and CSO of Tmab Therapeutics, about the application of ADCs in cancer treatment. This article is based on that interview.

Have a read of our BCI Launch Issue here    ●    Want to see more from Bioconjugation Insights? Sign up here